CancerNetwork·4 min read·hard
26 A Nomogram for Predicting High Axillary Disease Burden in Patients With Localized HR+, HER2-Negative Breast Cancer Following Neoadjuvant Chemotherapy
N
Neha Kalakuntla, Yulun Liu, Holly Grace, Marilyn Leitch, Asal Rahimi, Mona Arbab, Narine Wandrey, Deborah Farr, MD, Heather McArthur, MD, MPH, Sunati Sahoo, Stephen Seiler, Prasanna Alluri
✦AI Summary
Researchers at UT Southwestern and Parkland hospitals developed a nomogram to predict high axillary disease burden in breast cancer patients. The study identifies lymphovascular invasion and sentinel lymph node status as key predictors to help avoid unnecessary surgeries.
Why it matters
This tool helps clinicians personalize breast cancer treatment, reducing the risk of lymphedema and other morbidities associated with overtreatment.
Background
healthscience
Political Bias
Center
LeftLean LCenterLean RRight
Confidence: 90%
The article reports on clinical research findings without political or social commentary.
✦
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in